Differences in Surgical Management of Thyroid Cancer
Dr. Babak Larian, experienced Beverly Hills thyroid expert, discusses the differences in the surgical management of thyroid cancer.
Beverly Hills, CA (PRWEB) October 30, 2012
A spectrum of disparities currently exist in the surgical management of well-differentiated thyroid cancer, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Current ATA guidelines for well-differentiated thyroid cancer recommend therapeutic neck dissection for clinically involved or metastatic disease and prophylactic central neck dissection for advanced tumors.
"While there are established guidelines in place, it is evident that the surgical management of cervical nodes varies quite a bit,” says Babak Larian, MD, FACS, director at the CENTER for Advanced Head & Neck Surgery in Beverly Hills, California.
A team of researchers led by Katherine Hayes, MD, of Emory University in Atlanta, reviewed data on 127,192 patients with papillary and follicular thyroid cancer who were treated surgically from 1998 to 2009 to identify disparities in the extent of lymph node dissection during thyroidectomy. Variables examined included patient age, race, gender, insurance status, education level, hospital classification, surgical volume, and size of tumor.
Thyroidectomy alone was performed in 51.1% of the cases, while 48.9% also had lymph nodes dissected. Patients with tumors greater than 1cm were significantly more likely to have nodes removed during surgery relative to tumors that were less than 1 cm. Older patients and African Americans were, meanwhile, less likely to have any nodes removed.
"The research also revealed that patients treated at National Cancer Institute Designated Centers were more likely to have more than three lymph nodes removed, as were patients with tumors larger than 1cm,” explains Dr. Larian.
However, older patients and African Americans consistently had fewer lymph nodes removed.
"This shows that clinician preferences and patient characteristics contribute to a number of disparities in the extent of surgery for thyroid cancer,” concludes Dr. Larian.
Dr. Babak Larian is a board-certified diplomate of the American Board of Otolaryngology/Head and Neck Surgery, and a Fellow of both the American College of Surgeons and the American Head and Neck Society. He has considerable expertise in minimally invasive surgical approaches, image-guided surgery, as well as endoscopic laser surgery, which has made him one of the most sought-after physicians in the industry.
Dr. Larian has published articles in numerous scientific journals, conducted workshops, and offered presentations at several symposia and academic meetings, both nationally and internationally. He is the Chairman and Director of the CENTER for Advanced Head & Neck Surgery in Beverly Hills, and holds the incredibly prestigious position of Chief of Head & Neck Surgery at Cedars-Sinai Hospital in Los Angeles.
For more information, please visit http://www.advancedonc.com or call 310.461.0300.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb10069792.htmView Comments and Join the Discussion!